Nasally-Administered COVID-19 Vaccine Well Tolerated But Does Not Induce Strong Immune Responses, Investigators Say

The Hill (10/11, Choi) reports a study published in eBioMedicine “has found less-than-promising results for a nasally administered version of AstraZeneca’s COVID-19 vaccine, with immune responses observed in only ‘a minority of participants.’” Investigato...